Launaea fragilis extract attenuated arthritis in rats through modulation of IL-1β, TNF-α, IL-6, NF-κB, COX-2, IL-4, and IL-10

Inflammopharmacology. 2024 Aug;32(4):2427-2443. doi: 10.1007/s10787-024-01471-6. Epub 2024 May 7.

Abstract

Launaea fragilis (Asso) Pau is a Cholistan desert medicinal plant. Launaea species are used as traditional remedies against various inflammatory conditions. The current research was designed to evaluate the anti-nociceptive, anti-inflammatory, and anti-arthritic potential of ethanolic extract of L. fragilis (Et-LF). The plant extract was prepared by triple maceration. GC-MS screening explored the presence of various bioactive phytoconstituents including n-tetracosanol-1, 1-heptacosanol, and n-hexadecanoic acid. DPPH assay demonstrated the antioxidant potential of Et-LF. Safety profile data indicated that Et-LF was safe up to the oral dose of 5000 mg/kg in female rats. Anti-nociceptive activity of Et-LF was assessed in hot plate method and acetic acid-induced writhing model and the results suggested that Et-LF had significant analgesic effects in both animal models. Carrageenan, histamine, and serotonin-induced edema models were used to estimate the anti-inflammatory effects of Et-LF and were found to prevent paw edema development dose dependently. The anti-arthritic effect of Et-LF was estimated in CFA-induced arthritic rat model. Treatment with Et-LF 125, 250, 500 and flurbiprofen (FP) 10 mg/kg/day significantly attenuated the paw edema, reversed the reduced body weight, and restored the altered hematological parameters in arthritic rats. Gene expression studies revealed the significant downregulation of IL-1β, TNF-α, IL-6, NF‑κB, and COX-2, and upregulation of IL-4 and IL-10 in arthritic rats treated with various doses of plant extract. Histological evaluation of ankle joints showed that Et-LF mitigated pannus formation, infiltration of inflammatory cells, and fibrous connective tissue formation in the diseased rats. Thereof, it may be concluded that the recent study demonstrated the anti-nociceptive, anti-inflammatory, and anti-arthritic effects ascribed to the signifying presence of phytoconstituents in L. fragilis.

Keywords: Launaea fragilis; Complete freund’s adjuvant; Flurbiprofen; GC–MS; qRT-PCR.

MeSH terms

  • Analgesics / pharmacology
  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology
  • Arthritis / drug therapy
  • Arthritis, Experimental / drug therapy
  • Cyclooxygenase 2 / metabolism
  • Dose-Response Relationship, Drug
  • Edema* / drug therapy
  • Female
  • Interleukin-10 / metabolism
  • Interleukin-1beta / metabolism
  • Male
  • NF-kappa B* / metabolism
  • Plant Extracts* / administration & dosage
  • Plant Extracts* / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Plant Extracts
  • Anti-Inflammatory Agents
  • NF-kappa B
  • Cyclooxygenase 2
  • Analgesics
  • Interleukin-10
  • Interleukin-1beta
  • Antioxidants